Course Summary

Remimazolam is a novel, short-acting benzodiazepine ready for use in the procedural setting. Changing practice to include this agent has significant benefits including decreased turn-over time, increased patient safety profile, and potential cost savings over time in the out-patient setting when used by nurses trained in its safe administration. This lecture will compare the history of traditional and available agents, with a focus on current literature demonstrating the benefits of using Remimazolam compared to traditional medication regimens.

Presented at the AAMSN 2022 Conference

Objectives

The participant will be able to:

• Compare other traditional sedatives and hypnotics, short-acting agents, and Remimazolam in current literature.
• Define benefits of novel short-acting benzodiazepine for use in out-patient procedural areas.

10 Randomized Question Exam 80% or better required for CE credits.

Two attempts allowed.